Deerfield Management Company L.P. Series C lifted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 13.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,279,000 shares of the biotechnology company’s stock after purchasing an additional 154,000 shares during the quarter. Deerfield […]